Johnson & Johnson reported better-than-expected third-quarter sales and raised its full-year revenue guidance.
Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...
Third-quarter results exceeded estimates, but the company also lowered overall earnings expectations for 2024.
David Risinger, an analyst from Leerink Partners, maintained the Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
“We should all care about health equity because that is one more person who is going to have a challenge to care for their ...
The innovative medicine and medtech segments showed solid sales growth. Johnson & Johnson reported a strong increase in sales, but earnings fell due to one-time charges. In the wake of last year's ...
22h
Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), retaining the price ...
Johnson, 52, posted three clips showing how his “Face The Nation” answers on topics including hurricane relief and election ...
It was a relatively quiet day for Pittsburgh Pirates No. 3 prospect Termarr Johnson in his return to the lineup in the ...
Dwayne Johnson has previewed his "wild" festive blockbuster Red One ahead of its theatrical release next month. Also ...
Evan C. Plotkin, an artist and father of three, was diagnosed in 2021 with mesothelioma, a cancer of the lining of the lungs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback